AmerisourceBergen Story

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:6em;'>A</div>
ABC -- USA Stock  

USD 94.14  1.68  1.75%

AmerisourceBergen Net Income Per Employee is projected to increase significantly based on the last few years of reporting. The past year's Net Income Per Employee was at 44,712. The current year Earnings before Tax is expected to grow to about 1.1 B, whereas Revenue Per Employee is forecasted to decline to about 7.1 M. This story will go over AmerisourceBergen. We will evaluate if AmerisourceBergen shares are reasonably priced going into September. In this post, I will also go over some essential variables affecting AmerisourceBergen's products, and show how it may impact AmerisourceBergen outlook for active traders this year.
Published over a month ago
View all stories for AmerisourceBergen | View All Stories
Is AmerisourceBergen overvalued?
On a scale of 0 to 100, AmerisourceBergen holds a performance score of 11. The firm shows a Beta (market volatility) of -0.0629, which signifies not very significant fluctuations relative to the market. Let's try to break down what AmerisourceBergen's beta means in this case. As returns on the market increase, returns on owning AmerisourceBergen are expected to decrease at a much lower rate. During the bear market, AmerisourceBergen is likely to outperform the market. Although it is vital to follow AmerisourceBergen historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing AmerisourceBergen technical indicators, you can presently evaluate if the expected return of 0.34% will be sustainable into the future. Please makes use of AmerisourceBergen jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio to make a quick decision on whether AmerisourceBergen price patterns will revert.

And What about dividends?

A dividend is the distribution of a portion of AmerisourceBergen earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. AmerisourceBergen dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. AmerisourceBergen one year expected dividend income is about $1.09 per share.
As of September 23, 2020, Payment of Dividends and Other Cash Distributions is expected to decline to about (329.2 M). In addition to that, Dividend Yield is expected to decline to 0.0196.
Last ReportedProjected for 2020
Payment of Dividends and Other Cash Distributions-305.1 M-329.2 M
Dividend Yield 0.0218  0.0196 
Dividends per Basic Common Share 1.84  1.53 
Investing in dividend-paying stocks, such as AmerisourceBergen is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in AmerisourceBergen must own a stock before its ex-dividend date to receive its next dividend. This type of analysis is very useful when you want to generate a past dividend schedule and payout information for AmerisourceBergen. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.

How important is AmerisourceBergen's Liquidity

AmerisourceBergen financial leverage refers to using borrowed capital as a funding source to finance AmerisourceBergen ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. AmerisourceBergen financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between AmerisourceBergen's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for AmerisourceBergen, but it might be worth checking our own buy vs. sell analysis

What did AmerisourceBergen file with SEC?

The SEC filings are financial statements or other formal documents of AmerisourceBergen that are regularly submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make SEC filings and fintech professionals rely on these filings for information about companies they are evaluating for investment purposes. Please note, most SEC filings are available online through the SEC's EDGAR database. Please check here for more information.
Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to AmerisourceBergen shareholders may or may not be submitted as SEC does not always require it.
Financial Statements and Exhibits. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year
Submission of Matters to a Vote of Security Holders
Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to AmerisourceBergen shareholders may or may not be submitted as SEC does not always require it.

Exercise or conversion by John Chou of 5602 shares of AmerisourceBergen subject to Rule 16b-3

Legal trades by AmerisourceBergen insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
AmerisourceBergen insider trading alert for exercise of non-qualified stock option (right to buy) by John Chou, Executive Vice President, on 16th of September 2020. This event was filed by Amerisourcebergen Corp with SEC on 2020-09-16. Statement of changes in beneficial ownership - SEC Form 4. John Chou currently serves as executive vice president, chief legal officer and secretary of AmerisourceBergen [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking down the case for AmerisourceBergen

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AmerisourceBergen has an asset utilization ratio of 553.43 percent. This suggests that the company is making $5.53 for each dollar of assets. An increasing asset utilization means that AmerisourceBergen is more efficient with each dollar of assets it utilizes for everyday operations.

Possible September correction of AmerisourceBergen?

The skewness is down to -0.17 as of today. AmerisourceBergen currently demonstrates below-verage downside deviation. It has Information Ratio of 0.02 and Jensen Alpha of 0.25. However, we do advice investors to further question AmerisourceBergen expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk.

The Current Takeaway on AmerisourceBergen Investment

Whereas many other companies under the medical distribution industry are still a bit expensive, AmerisourceBergen may offer a potential longer-term growth to investors. All things considered, as of the 4th of August 2020, we believe that AmerisourceBergen is currently fairly valued with very low odds of financial turmoil in the next two years. Our present 30 days buy-hold-sell recommendation on the company is Cautious Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of AmerisourceBergen. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to